Investigation of arenesulfonyl-2-imidazolidinones as potent carbonic anhydrase inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 30, Issue 1, 2015, Pages 81-84

  Abdel Aziz, Alaa A M ^a,b   El Azab, Adel S ^a,c   Ekinci, Deniz ^d   Şentürk, Murat ^e   Supuran, Claudiu T ^f  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b University of Mansoura   (Egypt)

^c Al Azhar University   (Egypt)

^d ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^e AGRI IBRAHIM CECEN UNIVERSITY   (Turkey)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbonic anhydrase; Glaucoma; Imidazolidinone; Inhibitor

Indexed keywords

2 IMIDAZOLIDINONE DERIVATIVE; ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; ISOENZYME; ISOPROTEIN; SULFONAMIDE; 4-NITROPHENYL ACETATE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; IMIDAZOLIDINE DERIVATIVE; NITROPHENOL; RECOMBINANT PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COLUMN CHROMATOGRAPHY; COMPARATIVE STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; INHIBITION CONSTANT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; CHEMISTRY; ENZYME ASSAY; KINETICS; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ACETAZOLAMIDE; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE INHIBITORS; ENZYME ASSAYS; HUMANS; IMIDAZOLIDINES; KINETICS; NITROPHENOLS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84921311423     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2014.880696     Document Type: Article

References (32)

1. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Disc 2008;7:168-81.
2. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74.
3. Supuran CT. Carbonic anhydrases: catalytic mechanism, distribution and physiological roles. In: Supuran CT, Scozzafava A, Conway J, eds. Carbonic anhydrase - its inhibitors and activators. Boca Raton (FL): CRC; 2004:1-24.
4. Çavdar H, Ekinci D, Talaz O, et al. α-Carbonic anhydrases are sulfatases with cyclic diol monosulfate esters. J Enzyme Inhib Med Chem 2012;27:148-54.
5. Senturk M, Ekinci D, Goksu S, Supuran CT. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI. J Enzyme Inhib Med Chem 2012;27:365-9.
6. Ekinci D, Karagoz L, Ekinci D, et al. Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. J Enzyme Inhib Med Chem 2013;28:283-8.
7. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199-229.
8. Demirdag R, Comakli V, Senturk M, et al. Purification and characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity. Bioorg Med Chem 2013; 21:1522-5.
9. Durdagi S, Senturk M, Ekinci D, et al. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site. Bioorg Med Chem 2011;19:1381-9.
10. Alterio V, Vitale RM, Monti SM, et al. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. J Am Chem Soc 2006;128:8329-35.
11. Ekinci D, Ceyhun SB, Sentürk M, et al. Characterization and anions inhibition studies of an a-carbonic anhydrase from the teleost fish Dicentrarchus labrax. Bioorg Med Chem 2011;19:744-8.
12. Toth JE, Grindey GB, Ehlhardt WJ, et al. Sulfonimidamide analogs of oncolytic sulfonylureas. J Med Chem 1997;40:1018-25.
13. Medina JC, Shan B, Beckmann H, et al. Novel antineoplastic agents with efficacy against multidrug resistant tumor cells. Bioorg Med Chem Lett 1998;8:2653-6.
14. Ekinci D, Cavdar H, Talaz O, et al. NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II. Bioorg Med Chem 2010;18:3559-63.
15. Ekinci D, Cavdar H, Durdagi S, et al. Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI. Eur J Med Chem 2012;49:68-73.
16. Ekinci D, Kurbanoglu NI, Salamci E, et al. Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds. J Enzyme Inhib Med Chem 2012;27:845-8.
17. Alp C, Ekinci D, Gultekin MS, et al. A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis for carbonic anhydrase inhibitory potencies. Bioorg Med Chem 2010;18:4468-74.
18. Balaydin HT, Soyut H, Ekinci D, et al. Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols including natural products. J Enzyme Inhib Med Chem 2012;27:43-50.
19. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336-50.
20. Demirdag R, Yerlikaya E, Senturk M, et al. Heavy metal ion inhibition studies of human, sheep and fish a-carbonic anhydrases. J Enzyme Inhib Med Chem 2013;28:278-82.
21. Ceyhun SB, Senturk M, Yerlikaya E, et al. Purification and characterization of carbonic anhydrase from the teleost fish Dicentrarchus labrax (European seabass) liver and toxicological effects of metals on enzyme activity. Environ Toxicol Pharmacol 2011;32:69-74.
22. Forouzesh B, Takimoto CH, Goetz A, et al. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies. Clin Cancer Res 2003;9:5540-9.
23. Jung SH, Song JS, Lee HS, et al. Synthesis and evaluation of cytotoxic activity of novel arylsulfonylimidazolidinones. Bioorg Med Chem Lett 1996;6:2553-8.
24. Jung SH, Lee HS, Song JS, et al. Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones. Bioorg Med Chem Lett 1998;8:1547-50.
25. Lee SH, Park KL, Choi SU, et al. Effect of substituents on benzenesulfonyl motif of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicity. Arch Pharm Res 2000;23:579-84.
26. Kim I, Lee C, Kim H, Jung, S. Importance of sulfonylimidazolidinone motif of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicity: synthesis of 2-benzoyl-4-phenyl[1,2,5]thiazolidine-1,1-dioxides and their cytotoxcity. Arch Pharm Res 2003;26:9-14.
27. Zuliani V, Carmi C, Rivara M, et al. 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line. Eur J Med Chem 2009;44:3471-9.
28. Abdel-Aziz AA, El-Azab AS, El-Subbagh HI, et al. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones. Bioorg Med Chem Lett 2012;22:2008-14.
29. Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221-9.
30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-51.
31. Laemmli DK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
32. Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Pat 2006;16:1627-44.